Wilson Disease is a rare genetic disorder characterized by the body's inability to properly process and eliminate copper, leading to its accumulation in vital organs, primarily the liver and brain. This accumulation can result in serious health complications, including liver disease, neurological symptoms, and psychiatric issues. The condition, affecting roughly 1 in 30,000 people, manifests in a wide age range but typically surfaces between the ages of 5 and 35. Current treatments focus on managing copper levels in the body through chelation therapy and zinc supplementation to prevent further copper absorption. Despite available treatments, early diagnosis is critical to prevent irreversible damage and improve patient outcomes. Wilson Disease presents a complex challenge in healthcare, necessitating lifelong management and adherence to treatment to mitigate its effects on quality of life.